There is interest in the physiological effects of dopamine on the endocrine pancreas due to evidence in people that dopamine receptor antagonists can cause hyperinsulinemia and glucose intolerance [32, 33], while conversely, dopamine agonists can reduce insulin secretion and improve glycemic control [34, 35]. This evidence concerns the gene INS and Hyperinsulinemia.